18 May 2021 – HIV Vaccine Awareness Day

 “Only a truly effective, preventive HIV vaccine can limit and eventually eliminate the threat of AIDS.”

U.S. President Bill Clinton, 1997.

Today, the Journal of the International AIDS Society (JIAS) commemorates HIV Vaccine Awareness Day and reflects on the long-standing efforts to develop an HIV vaccine and the significance of SARS-CoV-2 vaccine development over the past year for the future of HIV vaccine research.

In “The path to find an HIV vaccine”, Glenda E Gray (South African Medical Research Council, South Africa) and Lawrence Corey (Fred Hutchinson Cancer Research Center, United States) discuss key HIV vaccine efficacy trials to date and the challenges in moving beyond vaccine candidates that only elicit strain-specific immune responses to those that could neutralize a wide diversity of HIV strains. They highlight recent scientific breakthroughs in eliciting broadly neutralizing antibodies in the context of both HIV and SARS-CoV-2 vaccine development, which bring new hope of making an HIV vaccine a reality.

Read more here.

Meanwhile, in “HIV Vaccines beyond COVID-19: Merits of Trust”, James G Kublin (Fred Hutchinson Cancer Research Center, United States) discusses the ways in which HIV and TB vaccine research will change going forward, thanks to lessons learned in public health and vaccine development over the course of the COVID-19 pandemic, particularly in terms of funding, biotechnology discoveries, workforce capacity and community participation and equity.

Read more here.

WP Twitter Auto Publish Powered By : XYZScripts.com